Correction: Reduction of Cardiovascular Risk Using Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Acute Coronary Syndrome: A Systematic Review
更正:应用前蛋白转化酶枯草杆菌蛋白酶/Kexin 9型抑制剂降低急性冠脉综合征患者心血管风险:一项系统评价
期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.c270
Rabih, Ahmad M; Niaj, Ahmad; Raman, Aishwarya; Uprety, Manish; Calero, Maria Jose; Villanueva, Maria Resah B; Joshaghani, Narges; Villa, Nicole; Badla, Omar; Goit, Raman; Saddik, Samia E; Dawood, Sarah N; Mohammed, Lubna